Page last updated: 2024-11-01

omeprazole and Amentia

omeprazole has been researched along with Amentia in 5 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
"To investigate the impact of MHRA DHPCs on prescribing practice in the secondary-care setting, looking specifically at a drug-drug interaction-the concomitant use of clopidogrel and proton pump inhibitors (PPIs) [as omeprazole]-and a drug-disease contraindication-the use of conventional (typical) antipsychotics in dementia."3.79The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis. ( Coleman, JJ; Dhami, A; Hodson, J; McIlroy, G; Thomas, SK, 2013)
"Pantoprazole was the most frequently used PPI agent."1.91Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany. ( Ahn, N; Baumeister, SE; Gerlach, R; Günter, A; Güntner, F; Linseisen, J; Meisinger, C; Nolde, M; Rückert-Eheberg, IM; Tauscher, M; Wawro, N, 2023)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Weiss, A2
Gingold-Belfer, R2
Boltin, D1
Beloosesky, Y1
Koren-Morag, N1
Meyerovitch, J1
Sharon, E1
Schmilovitz-Weiss, H2
Du, J1
Lai, Y1
Zhang, L1
Ahn, N1
Wawro, N1
Baumeister, SE1
Nolde, M1
Gerlach, R1
Tauscher, M1
Günter, A1
Güntner, F1
Rückert-Eheberg, IM1
Meisinger, C1
Linseisen, J1
Thomas, SK1
Hodson, J1
McIlroy, G1
Dhami, A1
Coleman, JJ1

Other Studies

5 other studies available for omeprazole and Amentia

ArticleYear
Chronic omeprazole use in the elderly is associated with decreased risk of dementia and cognitive decline.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:5

    Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole; Proton Pump Inhibitors; Retrospective Stu

2022
Chronic omeprazole use in the elderly: Is it related to the risk of dementia and cognitive decline?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:9

    Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole

2022
Author's Reply: "Chronic omeprazole use in the elderly: Is it related to the risk of dementia and cognitive decline?"
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:9

    Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole

2022
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
    Drugs & aging, 2023, Volume: 40, Issue:7

    Topics: Cognitive Dysfunction; Dementia; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors

2023
The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis.
    Drug safety, 2013, Volume: 36, Issue:7

    Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Clopidogrel; Communication; Dementia;

2013
chemdatabank.com